MVA Oncology Network meeting
Welcome to MVA Oncology Network and our 7th meeting – Oncology Animal Models
Oncology is one of the leading areas of research resulting in new therapeutics. Due to the challenges inherent in researching and developing anticancer therapeutics, predictive and robust preclinical models and approaches are critical.
Medicon Valley Alliance, together with one of our members – Envigo – is happy to invite you to the 7th MVA Oncology Network meeting, where we will discuss oncology animal models. What are the current opportunities and challenges of animal models – how do we ensure to get successful animal model translation to clinical practice?
|Date:||9 April, 2019|
|Time:||17:00 – 20:00|
|Venue:||Medicon Valley Alliance, Auditorium, Arne Jacobsens Allé 15, Ørestad City, 2300 Copenhagen S|
|Cost:||Free of charge for MVA members|
MVA Oncology Network is a professional and social network for professors, PI and corporate level executives from the regional oncology eco-system. The network focuses on best practice, experience and current challenges for public-private collaboration and the commercialization of oncology related R&D in the Medicon Valley region.
Joining the network is free of charge and is limited to Medicon Valley Alliance members only. However, non-member organizations and companies are welcome to attend one network event to evaluate if joining the network is relevant. If so, becoming a member of Medicon Valley Alliance will automatically make you able you to join the oncology network.
|17:00-17:30||Registration, networking and a bite to eat – meet the fellow participants|
Petter Hartman, CEO, Medicon Valley Alliance
|17:35-17:40||Sponsor of the event
Jens Viktor Nørgaard, Partner, European Patent Attorney, HØIBERG HØIBERG
|17:40-18.10||“Who are we?” 4 x 5 minute corporate/academic presentations
Markus Axelsson, Sales Director – RMS Benelux & Scandinavia, Envigo
Ramin Massoumi, Professor, Lund University
Tuula Kallunki, Associate Professor, Danish Cancer Society Research Center
Liselotte Nilsson, Head of Marketing, Phase Holographic Imaging PHI AB
|18:10-18.40||Mouse models for cancer immunotherapy
Maria Askmyr, Senior Scientist, Alligator Bioscience
|18:40-19.05||Orthoxenografts derived from adult and children. Present and future for the development of personalized medicine approaches
Alberto Villanueva, CSO & Co-founder, Xenopat, Spain
|19:05-19.25||Safety testing of anti-cancer products; regulatory requirements and species selection
Andy Makin, Scientific Director, Citoxlab Denmark
Medicon Valley Alliance
|19:30-20:00||Networking and refreshments|
|Host and sponsor||Sponsor|
MVA Oncology Network is a partnership between